. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: Can J Diabetes. 2014 Oct 22;39(1):73–77. doi: 10.1016/j.jcjd.2014.06.005

Table 3.

Mean and standard deviation (SD) of visual acuity (VA) and central subfield macular thickness (CST) according HbA1c levels.

		Initial CST(μm)	Final CST(μm)	p	Initial VA	Final VA	p
Insulin therapy group	HbA1c ≤ 7%	522.7	393.5	0.004^*	20/82	20/65	0.151
Insulin therapy group	HbA1c > 7%	444.7	355.8	0.003^*	20/70	20/50	0.054
Oral anti-diabetic agents group	HbA1c ≤ 7%	452.5	310.2	0.000^*	20/58	20/43	0.010^*
Oral anti-diabetic agents group	HbA1c > 7%	462.8	441.5	0.519	20/69	20/60	0.409

p<0.05